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Background
The discovery of BRCA1 and BRCA2 in the mid 1990’s
has transformed the management of breast and ovarian
cancer families. As part of the Malaysian Breast Cancer
Genetic Study [MyBrCa], University of Malaya and
CARIF have established a genetic counseling, genetic
testing and risk management clinic for high-risk breast
and ovarian cancer families. We studied the uptake and
acceptance of screening and prophylactic surgery
amongst women who carry a BRCA1 or BRCA2
mutation.
Methods
Between Jan 03 and Dec 10, a total of 384 patients in
the MyBrCa Study had full sequencing and large rear-
rangement analysis of both BRCA1 and BRCA2 genes.
Of these, 56 index patients (15%) were found to carry
deleterious mutations. All patients and their relatives
who carry mutations in these genes were offered follow-
up in a dedicated risk management clinic. The clinic is
run jointly by a consultant breast surgeon, gynae-oncol-
ogist, a genetic counselor and supported by a consultant
radiologist.
Results
Of 56 index patients, 40 (71%) chose to know their
genetic test results. In addition, 18 female relatives were
identified as carriers. Six had passed away. Thus, 52
female carriers are being followed-up [43 affected, 9
unaffected individuals]. Of these, 25 women or 62.5%
[24 previously affected by breast cancer and 1 unaffected
BRCA carriers] chose to attend a dedicated risk
management clinic at University Malaya Medical Centre.
Of these 24 affected women, 4 (17%) already had bilat-
eral mastectomies for bilateral breast cancers, 5 (24%)
chose to have risk reducing mastectomy (RRM), the
remaining 16 (76%) chose breast surveillance [only 6
had MRI] and none took up chemoprevention with
Tamoxifen. Of the 19 women who did not have pre-
vious TAHBSOs, 12 (63%) chose risk reducing salpingo-
oopherectomy (RRSO).
Conclusions
The uptake of RRM was lower than RRSO. This study
shows that although specialized risk management clinics
are acceptable in a high proportion of clients, reasons
for not wanting to attend a risk management clinic
should be explored.
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